Ebola vaccine efficacy trial ready to launch in Guinea
5 mars 2015The vaccine was developed by the Public Health Agency of Canada. A second vaccine will be tested in a sequential study, as supply becomes available.
The vaccine was developed by the Public Health Agency of Canada. A second vaccine will be tested in a sequential study, as supply becomes available.
A new WHO guideline recommends adults and children reduce their daily intake of free sugars to less than 10% of their total energy intake. A (…)
Some 1.1 billion teenagers and young adults are at risk of hearing loss due to the unsafe use of personal audio devices, including smartphones, (…)
Raging conflict and beleaguered health services are threatening the health of tens of millions of people across the Central African Republic, (…)
Today, the World Health Organization’s Regional Director for Africa, Dr Matshidiso Moeti, wraps up her visit to Sierra Leone, her first to an (…)
The goal of interrupting chains of Ebola virus transmission depends heavily on laboratory support. This support is needed to confirm or discard (…)
Since the death of Liberian national Thomas Eric Duncan in Texas on 8 October and the Ebola infection of two US nurses that treated him, there (…)
The third meeting of the Emergency Committee convened by the WHO Director-General under the IHR 2005 regarding the 2014 Ebola virus disease (EVD, (…)
Ebola virus disease currently has no vaccines or medicines approved by national regulatory authorities for use in humans save for the purpose of (…)
During the past weeks, a WHO team of emergency experts worked together with President Ellen Johnson Sirleaf and members of her government to (…)
After two days of discussion on potential Ebola therapies and vaccines, more than 150 participants, representing the fields of research and (…)
On 30 August 2014, Senegal’s Ministry of Public Health and Social Affairs provided WHO with details about a case of Ebola virus disease (EVD) (…)